Multicenter evaluation of MRSASelect II chromogenic agar for identification of methicillin-resistant staphylococcus aureus from wound and nasal specimens

Journal of Clinical Microbiology

Volumn 54, Issue 2, 2016, Pages 305-311

  Hernandez, Diana R ^a   Newton, Duane W ^b   Ledeboer, Nathan A ^c   Buchan, Blake ^c   Young, Carol ^b   Clark, Andrew E ^d   Connoly, Jessica ^c   Wolk, Donna M ^a  

^a GEISINGER HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOXITIN; ANTIINFECTIVE AGENT; CHROMOGENIC SUBSTRATE;

AGAR MEDIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM DETECTION; DRUG EFFECT; HUMAN; INCUBATION TIME; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NOSE SMEAR; PHENOTYPE; PRIORITY JOURNAL; WOUND; CLINICAL TRIAL; DISK DIFFUSION; INJURY; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTICENTER STUDY; NOSE CAVITY; PREVALENCE; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARDS; STAPHYLOCOCCAL INFECTIONS; WORKFLOW;

ANTI-BACTERIAL AGENTS; CHROMOGENIC COMPOUNDS; DISK DIFFUSION ANTIMICROBIAL TESTS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; NASAL CAVITY; PHENOTYPE; PREVALENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; WORKFLOW; WOUNDS AND INJURIES;

EID: 84956690099     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02410-15     Document Type: Article

References (30)

1. Jevons MP. 1961. "Celbenin"-resistant staphylococci. Br Med J 1:113-114. http://dx.doi.org/10.1136/bmj.1.5219.124.
2. Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson TS, Tolson JS, Martone WJ. 1992. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol 13:582-586. http://dx.doi.org/10.1086/646432.
3. Ayliffe GAJ, Duckworth GJ, Brumfitt W, Casewell MW, Cooke EM, Cookson BD, Keane CT, Marples RR, Phillips I, Simmons NA, Williams JD. 1986. Guidelines for the control of epidemic methicillinresistant Staphylococcus aureus. J Hosp Infect 7:193-201. http://dx.doi.org/10.1016/0195-6701(86)90064-2.
4. Vandenbroucke-Grauls C. 1994. Epidemiology of staphylococcal infections-A European perspective. J Chemother 6(Suppl):S67-S70.
5. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM, SHEA. 2003. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 24:362-386. http://dx.doi.org/10.1086/502213.
6. Centers for Medicare and Medicaid Services. 2007. IPPS Annual proposed and final rules, and relevant correction notices: fiscal year 2008. Centers for Medicare and Medicaid Services, Baltimore, MD. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatient PPS/IPPS-Regulations-And-Notices-Items/CMS1228401.html. Accessed 29 June 2015.
7. Arcenas RC, Spadoni S, Mohammad A, Kiechle FL, Walker K, Fader RC, Perdreau-Remington F, Osiecki J, Liesenfeld O, Hendrickson S, Rao A. 2012. Multicenter evaluation of the LightCycler MRSA advanced test, the Xpert MRSA assay, and MRSASelect directly plated culture with simulated workflow comparison for the detection of methicillin-resistant Staphylococcus aureus in nasal swabs. J Mol Diagn 14:367-375. http://dx.doi.org/10.1016/j.jmoldx.2012.01.015.
8. Wassenberg M, Kluytmans J, Erdkamp S, Bosboom R, Buiting A, van Elzakker E, Melchers W, Thijsen S, Troelstra A, Vandenbroucke-Grauls C, Visser C, Voss A, Wolffs P, Wulf M, van Zwet T, de Wit A, Bonten M. 2012. Costs and benefits of rapid screening of methicillin-resistant Staphylococcus aureus carriage in intensive care units: A prospective multicenter study. Crit Care 16:R22. http://dx.doi.org/10.1186/cc11184.
9. Wolk DM, Picton E, Johnson D, Davis T, Pancholi P, Ginocchio CC, Finegold S, Welch DF, de Boer M, Fuller D, Solomon MC, Rogers B, Mehta MS, Peterson LR. 2009. Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol 47: 758-764. http://dx.doi.org/10.1128/JCM.01714-08.
10. Matheson A, Christie P, Stari T, Kavanagh K, Gould IM, Masterton R, Reilly JS. 2012. Nasal swab screening for methicillin-resistant Staphylococcus aureus-how well does it perform? A cross-sectional study. Infect Control Hosp Epidemiol 33:803-808. http://dx.doi.org/10.1086/666639.
11. Yang HY, Suh JT, Lee HJ. 2010. Evaluation of commercial selective agars in screening for methicillin-resistant Staphylococcus aureus. Ann Clin Lab Sci 40:252-256.
12. Buchan BW, Ledeboer NA. 2010. Identification of two borderline oxacillin-resistant strains of Staphylococcus aureus from routine nares swab specimens by one of three chromogenic agars evaluated for the detection of MRSA. Am J Clin Pathol 134:921-927. http://dx.doi.org/10.1309/AJCPO9TOID1EPUIM.
13. Flayhart D, Hindler JF, Bruckner DA, Hall G, Shrestha RK, Vogel SA, Richter SS, Howard W, Walther R, Carroll KC. 2005. Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares. J Clin Microbiol 43:5536-5540. http://dx.doi.org/10.1128/JCM.43.11.5536-5540.2005.
14. Wolk DM, Marx JL, Dominguez L, Driscoll D, Schifman RB. 2009. Comparison of MRSASelect agar, CHROMagar methicillin-resistant Staphylococcus aureus (MRSA) medium, and Xpert MRSA PCR for detection of MRSA in nares: diagnostic accuracy for surveillance samples with various bacterial densities. J Clin Microbiol 47:3933-3936. http://dx.doi.org/10.1128/JCM.00601-09.
15. Harrington AT, Mahlen SD, Clarridge JE, III. 2010. Significantly larger numbers of methicillin-resistant Staphylococcus aureus bacteria are recovered from polymicrobial respiratory and wound sites by use of chromogenic primary media than by use of conventional culture. J Clin Microbiol 48:1350-1353. http://dx.doi.org/10.1128/JCM.01770-09.
16. Manickam K, Walkty A, Lagace-Wiens PR, Adam H, Swan B, McAdam B, Pieroni P, Alfa M, Karlowsky JA. 2013. Evaluation of MRSASelect (TM) chromogenic medium for the early detection of methicillin-resistant Staphylococcus aureus from blood cultures. Can J Infect Dis Med Microbiol 24:e113-e116.
17. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial disk susceptibility tests; approved standard-11th ed. CLSI document M02-A11. Clinical and Laboratory Standards Institute, Wayne, PA.
18. Urbaniak GC, Plous S. 2015. Research randomizer. https://www.randomizer.org/.
19. Veguilla W, Peak KK, Luna VA, Roberts JC, Davis CR, Cannons AC, Amuso P, Cattani J. 2008. Two-year study evaluating the potential loss of methicillin resistance in a methicillin-resistant Staphylococcus aureus culture collection. J Clin Microbiol 46:3494-3497. http://dx.doi.org/10.1128/JCM.00654-08.
20. Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Fridkin S, Emerging Infections Program-Active Bacterial Core Surveillance MRSA Surveillance Investigators. 2013. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 173:1970-1978.
21. Robicsek A, Beaumont JL, Peterson LR. 2009. Duration of colonization with methicillin-resistant Staphylococcus aureus. Clin Infect Dis 48:910-913. http://dx.doi.org/10.1086/597296.
22. Centers for Disease Control and Prevention. 2014. MRSA Tracking. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/mrsa/tracking/index.html.
23. Denys GA, Renzi PB, Koch KM, Wissel CM. 2013. Three-way comparison of BBL CHROMagar MRSA II, MRSASelect, and spectra MRSA for detection of methicillin-resistant Staphylococcus aureus isolates in nasal surveillance cultures. J Clin Microbiol 51:202-205. http://dx.doi.org/10.1128/JCM.02022-12.
24. Warren DK, Liao RS, Merz LR, Eveland M, Dunne WM, Jr. 2004. Detection of methicillin-resistant Staphylococcus aureus directly from nasal swab specimens by a real-Time PCR assay. J Clin Microbiol 42:5578-5581. http://dx.doi.org/10.1128/JCM.42.12.5578-5581.2004.
25. Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. 2007. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 57:7-13. http://dx.doi.org/10.1016/j.diagmicrobio.2006.05.009.
26. Compernolle V, Verschraegen G, Claeys G. 2007. Combined use of Pastorex Staph-Plus and either of two new chromogenic agars, MRSA ID and CHROMagar MRSA, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 45:154-158. http://dx.doi.org/10.1128/JCM.01115-06.
27. Lee S, Park YJ, Yoo JH, Kahng J, Jeong IH, Kwon YM, Han K. 2008. Comparison of culture screening protocols for methicillin-resistant Staphylococcus aureus (MRSA) using a chromogenic agar (MRSA-Select). Ann Clin Lab Sci 38:254-257.
28. Jones EM, Bowker KE, Cooke R, Marshall RJ, Reeves DS, MacGowan AP. 1997. Salt tolerance of EMRSA-16 and its effect on the sensitivity of screening cultures. J Hosp Infect 35:59-62. http://dx.doi.org/10.1016/S0195-6701(97)90168-7.
29. Lee S, Park YJ, Park KG, Jekarl DW, Chae H, Yoo JK, Seo SW, Choi JE, Lim JH, Heo SM, Seo JH. 2013. Comparative evaluation of three chromogenic media combined with broth enrichment and the real-Time PCRbased Xpert MRSA assay for screening of methicillin-resistant Staphylococcus aureus in nasal swabs. Ann Lab Med 33:255-260. http://dx.doi.org/10.3343/alm.2013.33.4.255.
30. García-Álvarez L, Holden MT, Lindsay H, Webb CR, Brown DF, Curran MD, Walpole E, Brooks K, Pickard DJ, Teale C, Parkhill J, Bentley SD, Edwards GF, Girvan EK, Kearns AM, Pichon B, Hill RL, Larsen AR, Skov RL, Peacock SJ, Maskell DJ, Holmes MA. 2011. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the United Kingdom and Denmark: A descriptive study. Lancet Infect Dis 11:595-603. http://dx.doi.org/10.1016/S1473-3099(11)70126-8.